Mrna-Type Introns in U6 Small Nuclear RNA Genes: Implications for the Catalysis in Pre-Mrna Splicing
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Coupling of Spliceosome Complexity to Intron Diversity
bioRxiv preprint doi: https://doi.org/10.1101/2021.03.19.436190; this version posted March 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Coupling of spliceosome complexity to intron diversity Jade Sales-Lee1, Daniela S. Perry1, Bradley A. Bowser2, Jolene K. Diedrich3, Beiduo Rao1, Irene Beusch1, John R. Yates III3, Scott W. Roy4,6, and Hiten D. Madhani1,6,7 1Dept. of Biochemistry and Biophysics University of California – San Francisco San Francisco, CA 94158 2Dept. of Molecular and Cellular Biology University of California - Merced Merced, CA 95343 3Department of Molecular Medicine The Scripps Research Institute, La Jolla, CA 92037 4Dept. of Biology San Francisco State University San Francisco, CA 94132 5Chan-Zuckerberg Biohub San Francisco, CA 94158 6Corresponding authors: [email protected], [email protected] 7Lead Contact 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.19.436190; this version posted March 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. SUMMARY We determined that over 40 spliceosomal proteins are conserved between many fungal species and humans but were lost during the evolution of S. cerevisiae, an intron-poor yeast with unusually rigid splicing signals. We analyzed null mutations in a subset of these factors, most of which had not been investigated previously, in the intron-rich yeast Cryptococcus neoformans. -
U6 Small Nuclear RNA Is Transcribed by RNA Polymerase III (Cloned Human U6 Gene/"TATA Box"/Intragenic Promoter/A-Amanitin/La Antigen) GARY R
Proc. Nati. Acad. Sci. USA Vol. 83, pp. 8575-8579, November 1986 Biochemistry U6 small nuclear RNA is transcribed by RNA polymerase III (cloned human U6 gene/"TATA box"/intragenic promoter/a-amanitin/La antigen) GARY R. KUNKEL*, ROBIN L. MASERt, JAMES P. CALVETt, AND THORU PEDERSON* *Cell Biology Group, Worcester Foundation for Experimental Biology, Shrewsbury, MA 01545; and tDepartment of Biochemistry, University of Kansas Medical Center, Kansas City, KS 66103 Communicated by Aaron J. Shatkin, August 7, 1986 ABSTRACT A DNA fragment homologous to U6 small 4A (20) was screened with a '251-labeled U6 RNA probe (21, nuclear RNA was isolated from a human genomic library and 22) using a modified in situ plaque hybridization protocol sequenced. The immediate 5'-flanking region of the U6 DNA (23). One of several positive clones was plaque-purified and clone had significant homology with a potential mouse U6 gene, subsequently shown by restriction mapping to contain a including a "TATA box" at a position 26-29 nucleotides 12-kilobase-pair (kbp) insert. A 3.7-kbp EcoRI fragment upstream from the transcription start site. Although this containing U6-hybridizing sequences was subcloned into sequence element is characteristic of RNA polymerase II pBR322 for further restriction mapping. An 800-base-pair promoters, the U6 gene also contained a polymerase III "box (bp) DNA fragment containing U6 homologous sequences A" intragenic control region and a typical run of five thymines was excised using Ava I and inserted into the Sma I site of at the 3' terminus (noncoding strand). The human U6 DNA M13mp8 replicative form DNA (M13/U6) (24). -
Protein-Free Small Nuclear Rnas Catalyze a Two-Step Splicing Reaction
Protein-free small nuclear RNAs catalyze a two-step splicing reaction Saba Valadkhan1,2, Afshin Mohammadi1, Yasaman Jaladat, and Sarah Geisler Center for RNA Molecular Biology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106 Edited by Joan A. Steitz, Yale University, New Haven, CT, and approved May 13, 2009 (received for review March 3, 2009) Pre-mRNA splicing is a crucial step in eukaryotic gene expression and is carried out by a highly complex ribonucleoprotein assembly, the spliceosome. Many fundamental aspects of spliceosomal function, including the identity of catalytic domains, remain unknown. We show that a base-paired complex of U6 and U2 small nuclear RNAs, in the absence of the Ϸ200 other spliceosomal components, performs a two-step reaction with two short RNA oligonucleotides as substrates that results in the formation of a linear RNA product containing portions of both oligonucleotides. This reaction, which is chemically identical to splicing, is dependent on and occurs in proximity of sequences known to be critical for splicing in vivo. These results prove that the complex formed by U6 and U2 RNAs is a ribozyme and can potentially carry out RNA-based catalysis in the spliceosome. catalysis ͉ ribozymes ͉ snRNAs ͉ spliceosome ͉ U6 xtensive mechanistic and structural similarities between spliceoso- BIOCHEMISTRY Emal small nuclear RNAs (snRNAs) and self-splicing group II introns (1, 2) have led to the hypothesis that the snRNAs are evolu- Fig. 1. The U6/U2 complex and splicing substrates. (A) The U6/U2 construct used tionary descendents of group II–like introns and thus could similarly in this study, which contains the central domains of the human U6 and U2 snRNAs. -
Nuclear Expression of a Group II Intron Is Consistent with Spliceosomal Intron Ancestry
Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press Nuclear expression of a group II intron is consistent with spliceosomal intron ancestry Venkata R. Chalamcharla, M. Joan Curcio, and Marlene Belfort1 Center for Medical Sciences, Wadsworth Center, New York State Department of Health, Albany, New York 12208, USA; and School of Public Health, State University of New York at Albany, Albany, New York 12201, USA Group II introns are self-splicing RNAs found in eubacteria, archaea, and eukaryotic organelles. They are mechanistically similar to the metazoan nuclear spliceosomal introns; therefore, group II introns have been invoked as the progenitors of the eukaryotic pre-mRNA introns. However, the ability of group II introns to function outside of the bacteria-derived organelles is debatable, since they are not found in the nuclear genomes of eukaryotes. Here, we show that the Lactococcus lactis Ll.LtrB group II intron splices accurately and efficiently from different pre-mRNAs in a eukaryote, Saccharomyces cerevisiae. However, a pre-mRNA harboring a group II intron is spliced predominantly in the cytoplasm and is subject to nonsense-mediated mRNA decay (NMD), and the mature mRNA from which the group II intron is spliced is poorly translated. In contrast, a pre-mRNA bearing the Tetrahymena group I intron or the yeast spliceosomal ACT1 intron at the same location is not subject to NMD, and the mature mRNA is translated efficiently. Thus, a group II intron can splice from a nuclear transcript, but RNA instability and translation defects would have favored intron loss or evolution into protein-dependent spliceosomal introns, consistent with the bacterial group II intron ancestry hypothesis. -
Mediator Is Essential for Small Nuclear and Nucleolar RNA Transcription in Yeast
bioRxiv preprint doi: https://doi.org/10.1101/352906; this version posted June 21, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Mediator is essential for small nuclear and nucleolar RNA transcription in yeast 2 3 Jason P. Tourignya, Moustafa M. Saleha, Gabriel E. Zentnera# 4 5 aDepartment of Biology, Indiana University, Bloomington, IN, USA 6 7 #Address correspondence to Gabriel E. Zentner, [email protected] 8 9 Running head: Mediator regulates sn/snoRNAs 10 11 Abstract word count: 198 12 Introduction/results/discussion word count: 3,085 13 Materials and methods word count: 1,433 1 bioRxiv preprint doi: https://doi.org/10.1101/352906; this version posted June 21, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 14 Abstract 15 Eukaryotic RNA polymerase II (RNAPII) transcribes mRNA genes as well as non-protein coding 16 RNAs (ncRNAs) including small nuclear and nucleolar RNAs (sn/snoRNAs). In metazoans, 17 RNAPII transcription of sn/snoRNAs is facilitated by a number of specialized complexes, but no 18 such complexes have been discovered in yeast. It has thus been proposed that yeast 19 sn/snoRNA promoters use the same complement of factors as mRNA promoters, but the extent 20 to which key regulators of mRNA genes act at sn/snoRNA genes in yeast is unclear. -
Explore the RNA Universe!
Explore the RNA Universe! Circulating cell-free RNA (ccfRNA) Exosomes Exosomal RNA (exRNA) Ribonuclease P (RNase P) Small (short) interfering RNA (siRNA) Pre-miRNA Small nucleolar RNA Exportin-5 (snoRNA) MicroRNA (miRNA) Drosha Pri-miRNA RISC DGCR8 Ribosomal RNA (rRNA) Small nuclear RNA Ribonuclease MRP Y RNA (snRNA) (RNase MRP) Long non-coding RNA Messenger RNA (mRNA) (IncRNA) Transfer RNA (tRNA) Telomerase RNA Ribosomes Signal recognition particle RNA (SRP RNA) Mitochondria Piwi-interacting RNA (piRNA) Sample to Insight Explore the RNA Universe! RNA function RNA type Detailed role in the cell Protein synthesis Messenger RNA (mRNA) Carrying the genetic information copied from DNA in the form of three-nucleotide bases “codon,” each specifying a particular amino acid for protein synthesis at the ribosomes. Purify with: RNeasy® Plus Kits*, RNeasy Kits*, QIAamp® RNA Blood Kit*, QIAcube® Assay using: QuantiNova® Kits, RT2 Profiler™ PCR Assays and Arrays, Rotor-Gene® Q , QIAseq™ Targeted RNA Panels, QIAseq Stranded mRNA Select Library Kit, QIAseq UPX 3' Targeted RNA Panel, QIAseq UPX 3' Transcriptome RNA Library Kit, QIAseq Targeted RNAscan Panels, QIAseq FX Single Cell RNA Library Kit Transfer RNA Adapter molecule bringing the amino acid corresponding to a specific mRNA codon to the ribosome. Having an anticodon (complementary to the codon), a site (tRNA) binding a specific amino acid and a site binding aminoacyl-tRNA synthetase (enzyme catalyzing amino acid-tRNA binding). Ribosomal RNA (rRNA) RNA component of the ribosome, where protein is translated. Ribosomes align the anticodon of tRNA with the mRNA codon and are required for the peptidyl transferase activity catalyzing the assembly of amino acids into protein chains. -
The Differential Interaction of Snrnps with Pre-Mrna Reveals Splicing Kinetics in Living Cells
Published October 4, 2010 This article has original data in the JCB Data Viewer JCB: Article http://jcb-dataviewer.rupress.org/jcb/browse/3011 The differential interaction of snRNPs with pre-mRNA reveals splicing kinetics in living cells Martina Huranová,1 Ivan Ivani,1 Aleš Benda,2 Ina Poser,3 Yehuda Brody,4,5 Martin Hof,2 Yaron Shav-Tal,4,5 Karla M. Neugebauer,3 and David StanČk1 1Institute of Molecular Genetics and 2J. Heyrovský Institute of Physical Chemistry, Academy of Sciences of the Czech Republic, 142 20 Prague, Czech Republic 3Max Planck Institute for Molecular Cell Biology and Genetics, 01307 Dresden, Germany 4The Mina and Everard Goodman Faculty of Life Sciences and 5Institute for Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan 52900, Israel recursor messenger RNA (pre-mRNA) splicing is Core components of the spliceosome, U2 and U5 snRNPs, catalyzed by the spliceosome, a large ribonucleo- associated with pre-mRNA for 15–30 s, indicating that protein (RNP) complex composed of five small nuclear splicing is accomplished within this time period. Additionally, P Downloaded from RNP particles (snRNPs) and additional proteins. Using live binding of U1 and U4/U6 snRNPs with pre-mRNA oc- cell imaging of GFP-tagged snRNP components expressed curred within seconds, indicating that the interaction of at endogenous levels, we examined how the spliceosome individual snRNPs with pre-mRNA is distinct. These results assembles in vivo. A comprehensive analysis of snRNP are consistent with the predictions of the step-wise model dynamics in the cell nucleus enabled us to determine of spliceosome assembly and provide an estimate on the snRNP diffusion throughout the nucleoplasm as well as rate of splicing in human cells. -
Sequences at the Exon-Intron Boundaries* (Split Gene/Mrna Splicing/Eukaryotic Gene Structure) R
Proc. Nati. Acad. Sci. USA Vol. 75, No. 10, pp. 4853-4857, October 1978 Biochemistry Ovalbumin gene: Evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries* (split gene/mRNA splicing/eukaryotic gene structure) R. BREATHNACH, C. BENOIST, K. O'HARE, F. GANNON, AND P. CHAMBON Laboratoire de Genetique Mol6culaire des Eucaryotes du Centre National de la Recherche Scientifique, Unite 44 de l'Institut National de la Sant6 et de la Recherche MWdicale, Institut de Chimie Biologique, Facult6 de Melecine, Strasbourg 67085, France Communicated by A. Frey-Wyssling, July 31, 1978 ABSTRACT Selected regions of cloned EcoRI fragments the 5' end of ov-mRNA and have revealed some interesting of the chicken ovalbumin gene have been sequenced. The po- features in the DNA sequences at exon-intron boundaries. sitions where the sequences coding for ovalbumin mRNA (ov- mRNA) are interrupted in the genome have been determined, and a previously unreported interruption in the DNA sequences MATERIALS AND METHODS coding for the 5' nontranslated region of the messenger has been discovered. Because directly repeated sequences are found at Plasmid pCR1 ov 2.1 containing the ov-ds-cDNA insert was exon-intron boundaries, the nucleotide sequence alone cannot prepared as described (9). EcoRI fragments "b," "c," and "d" define unique excision-ligation points for the processing of a previously cloned in X vectors (3) were transferred to the plas- possible ov-mRNA precursor. However, the sequences in these mid pBR 322. An EcoRI/HindIII of the EcoRI boundary regions share common features; this leads to the fragment proposal that there are, in fact, unique excision-ligation points fragment "a" containing the entirety of exon 7 (Fig. -
POLYADENYLATION REGULATION of U1A Mrna: CHARACTERIZING
STUDIES OF POLYADENYLATION REGULATION OF U1A mRNA BY AN RNP COMPLEX CONTAINING U1A AND U1 snRNP By ROSE MARIE CARATOZZOLO A dissertation submitted to the Graduate School – New Brunswick Rutgers, The State University of New Jersey and The Graduate School of Biomedical Sciences University of Medicine and Dentistry of New Jersey In partial fulfillment of the requirements for the degree of Doctor of Philosophy Graduate Program in Biochemistry Written under the direction of Samuel I. Gunderson, Ph.D., And approved by _____________________________ _____________________________ _____________________________ _____________________________ New Brunswick, New Jersey January, 2011 ABSTRACT OF THE DISSERTATION STUDIES OF POLYADENYLATION REGULATION OF U1A mRNA BY AN RNP COMPLEX CONTAINING U1A AND U1 snRNP By Rose Marie Caratozzolo Dissertation Director: Samuel I. Gunderson, Ph.D. The 3’-end processing of nearly all eukaryotic pre-mRNAs comprises multiple steps which culminate in the addition of a poly(A) tail, which is essential for mRNA stability, translation, and export. Consequently, polyadenylation regulation is an important component of gene expression. One way to regulate polyadenylation is to inhibit the activity of a single poly(A) site, as exemplified by the U1A protein that negatively autoregulates itself by binding to a Polyadenylation Inhibitory Element (PIE) site within the 3’ UTR of its own pre-mRNA. U1 snRNP, which is primarily involved in splice site recognition, inhibits poly(A) site activity in papillomaviruses by binding to 5’ splice site-like sequences, which have recently been named “U1-sites”. Here, a recently identified U1-site in the human U1A 3'UTR is examined and shown to synergize with the adjacent PIE site to inhibit polyadenylation. -
Guide for Morpholino Users: Toward Therapeutics
Open Access Journal of Drug Discovery, Development and Delivery Special Article - Antisense Drug Research and Development Guide for Morpholino Users: Toward Therapeutics Moulton JD* Gene Tools, LLC, USA Abstract *Corresponding author: Moulton JD, Gene Tools, Morpholino oligos are uncharged molecules for blocking sites on RNA. They LLC, 1001 Summerton Way, Philomath, Oregon 97370, are specific, soluble, non-toxic, stable, and effective antisense reagents suitable USA for development as therapeutics and currently in clinical trials. They are very versatile, targeting a wide range of RNA targets for outcomes such as blocking Received: January 28, 2016; Accepted: April 29, 2016; translation, modifying splicing of pre-mRNA, inhibiting miRNA maturation and Published: May 03, 2016 activity, as well as less common biological targets and diagnostic applications. Solutions have been developed for delivery into a range of cultured cells, embryos and adult animals; with development of a non-toxic and effective system for systemic delivery, Morpholinos have potential for broad therapeutic development targeting pathogens and genetic disorders. Keywords: Splicing; Duchenne muscular dystrophy; Phosphorodiamidate morpholino oligos; Internal ribosome entry site; Nonsense-mediated decay Morpholinos: Research Applications, the transcript from miRNA regulation; Therapeutic Promise • Block regulatory proteins from binding to RNA, shifting Morpholino oligos bind to complementary sequences of RNA alternative splicing; and get in the way of processes. Morpholino oligos are commonly • Block association of RNAs with cytoskeletal motor protein used to prevent a particular protein from being made in an organism complexes, preventing RNA translocation; or cell culture. Morpholinos are not the only tool used for this: a protein’s synthesis can be inhibited by altering DNA to make a null • Inhibit poly-A tailing of pre-mRNA; mutant (called a gene knockout) or by interrupting processes on RNA • Trigger frame shifts at slippery sequences; (called a gene knockdown). -
The Lifespan of an MLL-Rearranged Therapy-Related Paediatric AML
Bone Marrow Transplantation (2015) 50, 1382–1384 © 2015 Macmillan Publishers Limited All rights reserved 0268-3369/15 www.nature.com/bmt LETTER TO THE EDITOR From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AML Bone Marrow Transplantation (2015) 50, 1382–1384; doi:10.1038/ amplified by RT-PCR. DCP1A is predominantly cytoplasmic as part bmt.2015.155; published online 6 July 2015 of a protein complex involved in degradation of mRNAs.8 Upon stimulation by TGFB1 and interaction with SMAD4, it becomes nuclear contributing to the transactivation of TGF-α target genes.9 Therapy-related AML (tAML) is one of the most prevalent DCP1A is a novel MLL fusion partner in AML. The in vitro secondary malignant neoplasms in paediatric cancer survivors. transforming capacity of MLL-DCP1A was weaker than the more Estimates of incidence and association with causative chemo- common MLL-ENL fusion but it could nevertheless be clearly therapeutic agents are mainly based on epidemiological data. verified by colony formation in retroviral transduction-replating 10 Individual courses revealing the exact timing of the first clone assays (Figure 1d). appearance and its development under treatment are limited The cumulative sampling of bone marrow during preceding owing to the overall low incidence, which does not justify neuroblastoma treatment offered the unique possibility to repeated bone marrow sampling in order to detect the occurrence quantitatively backtrack the origin of the tAML by quantitative of potentially leukemic cells. real-time PCR using the genomic MLL-DCP1A breakpoint as a Here we report a unique case of tAML arising after neuro- molecular marker. -
Spliceosomal Intronogenesis
Spliceosomal intronogenesis Sujin Leea and Scott W. Stevensb,c,1 aGraduate Program in Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712; bDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712; and cInstitute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712 Edited by Jef D. Boeke, New York University School of Medicine, New York, NY, and approved April 20, 2016 (received for review March 30, 2016) The presence of intervening sequences, termed introns, is a defining it is clear that introns massively infiltrated the genome of the last characteristic of eukaryotic nuclear genomes. Once transcribed into eukaryotic common ancestor and that introns have continued to be pre-mRNA, these introns must be removed within the spliceosome gained and lost over evolutionary time (11, 18). before export of the processed mRNA to the cytoplasm, where it is Here we report the use of a reporter system designed to detect translated into protein. Although intron loss has been demonstrated events of intron gain and intron loss in the budding yeast Sac- experimentally, several mysteries remain regarding the origin and charomyces cerevisiae. With this reporter, we have captured, to our propagation of introns. Indeed, documented evidence of gain of an knowledge, the first verified examples of intron gain via intron intron has only been suggested by phylogenetic analyses. We report transposition in any eukaryote. the use of a strategy that detects selected intron gain and loss events. We have experimentally verified, to our knowledge, the first demon- Results strations of intron transposition in any organism.